Skip to content
Research Article Open access CC BY 3.0

Drug Resistance in Mycobacterium tuberculosis Isolates from Northeastern Sudan

S. O. Hassan, M. T. Musa, H. M. Elsheikh, A. M. S. Eleragi, N. S. Saeed

Journal of Advances in Medicine and Medical Research · pp. 424–433 · Published 26 Jun 2012

10.9734/BJMMR/2012/1404

Abstract

The present study intended to determine the drug resistance patterns of Mycobacterium tuberculosis isolates among human new tuberculosis cases from northeastern Sudan using conventional and molecular techniques. Of 100 mycobacterial isolates tested by proportion method, 6% and 2% were identified, respectively, as multi drug resistant-tuberculosis (MDR-TB) and non-multi drug resistant-rifampicin (non-MDR-RIF). A total of 8% was found resistant to rifampicin (RIF), 13% to isoniazid (INH), 34% to streptomycin (STM) and 12% to ethambutol (EMB). Mono-resistant were 0% for RIF, 1% INH, 18% STM and 3% ETH. The remaining 61% isolates were identified as sensitive. Resistance to pyrazinamide was evaluated conventionally for the first time in this country and was found as low as 1%. Molecularly, mutations of MDR-TB, RIF, INH, EMB and STM resistant isolates were detected in 66.7%, 87.5%, 76.9%, 66.7% and 17.6% of corresponding conventional findings, respectively. The genetic mutations were related to the following codons: rpoB 531 (71.4%) and rpoB 526 (28.6%) for RIF, katG 315 (90%) and mabA-inhA-15 (10%) for INH, embB 306 (66.7%) for EMB and rpsL (17.6%) for STM. The study showed that drug resistant tuberculosis increased steadily and provided potentially valuable information on resistant genes circulating in the community. The rapid solving of this problem can benefit both public health and patient management.

Drug resistance Mycobacterium tuberculosis susceptibility Sudan

References (27)

  1. 1 Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update [DOI]
  2. 2 Multidrug-resistant Tuberculosis [DOI]
  3. 3 Worldwide Incidence of Multidrug‐Resistant Tuberculosis [DOI]
  4. 4 Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment [DOI]
  5. 5 Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis [DOI]
  6. 6 Drug Resistance inMycobacterium tuberculosis [DOI]
  7. 7 Drug resistance in Mycobacterium tuberculosis.
  8. 8 Tuberculosis in patients with HIV infection [DOI]
  9. 9 Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level [DOI]
  10. 10 Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa [DOI]
  11. 11 Contribution of kasA Analysis to Detection of Isoniazid-Resistant Mycobacterium tuberculosis in Singapore [DOI]
  12. 12 Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric Methods [DOI]
  13. 13 Rapid differentiation of Mycobacterium bovis and Mycobacterium tuberculosis based on a 12.7-kb fragment by a single tube multiplex-PCR [DOI]
  14. 14 Guidelines for speciation within the mycobacterium tuberculosis complex
  15. 15 DifferentialIdentification of Mycobacterium tuberculosis Complexand Nontuberculous Mycobacteria by Duplex PCR Assay Using the RNAPolymerase Gene( rpoB ) [DOI]
  16. 16 Inactivation of Mycobacterium tuberculosis for DNA Typing Analysis [DOI]
  17. 17 Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay [DOI]
  18. 18 Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility [DOI]
  19. 19 Molecular Analysis of Clinical Isolates of Mycobacterium tuberculosis Collected from Patients with Persistent Disease in the Khartoum Region of Sudan [DOI]
  20. 20 Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis [DOI]
  21. 21 Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain [DOI]
  22. 22 Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance inMycobacterium tuberculosis [DOI]
  23. 23 The Effects of Exposure Time, Drug Concentration, and Temperature on the Activity of Ethambutol versus Mycobacterium tuberculosis [DOI]
  24. 24 Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis. [DOI]
  25. 25 A survey of pulmonary tuberculosis in patients at Khartoum [DOI]
  26. 26 Corrigendum to “Rapid differentiation of Mycobacterium bovis and Mycobacterium tuberculosis based on a 12.7-kb fragment by a single tube multiplex-PCR” [Vet. Microbiol. 109 (2005) 211–216] [DOI]
  27. 27 Determination of the prevalence of tuberculosis with drug-resistant strains of Mycobacterium tuberculosis in Khartoum, Gazira and camps for displaced people, Sudan

Cited by 20

Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis

Khalid Hajissa, Mahfuza Marzan, Mubarak Ibrahim Idriss · Antibiotics · 2021

First-Line Drug Resistance Patterns of <i>Mycobacterium tuberculosis</i> Complex Isolates from Re-Treatment Patients from Sudan

Muatsim Ahmed Mohammed Adam, Hamdan Mustafa Hamdan Ali, Eltahir Awad Gasim Khalil · Journal of Tuberculosis Research · 2016

Resistance Patterns of Mycobacterium tuberculosis to First-Line Anti-TB Drugs in Kaduna State, North-Western Nigeria

Aliyu, M. S., Garba, I., Tijjani, M. B. · UMYU Journal of Microbiology Research (UJMR) · 2020

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

Monadil H. Ali, Alian A. Alrasheedy, Mohamed Azmi Hassali · Antibiotics · 2019

Tuberculosis drug resistance isolates from pulmonary tuberculosis patients, Kassala State, Sudan

Fatima A. Khalid, Zuhal A. Hamid, M.M. Mukhtar · The International Journal of Mycobacteriology · 2015

Conflict and tuberculosis in Sudan: a 10-year review of the National Tuberculosis Programme, 2004-2014

Sara A. Hassanain, Jeffrey K. Edwards, Emilie Venables · Conflict and Health · 2018

Mycobacterium tuberculosisComplex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan1

Yassir A. Shuaib, Eltahir A.G. Khalil, Lothar H. Wieler · Emerging Infectious Diseases · 2020

Showing 8 of 20 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

11

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.